CR8 3HCl (R)
CR8 3HCl (R) is a small molecule which can act as a CDK inhibitor. It is provided as a powder.
This product acts on the following target types: Kinase.
This product acts on the following biochemical pathways: Cell cycle, Apoptosis inducer, NFkappaB, Myc, Bcl.
This product may be interest in the following research areas and diseases: Neuroscience, Cell death, Ubiquitin/Proteasome, Cancer, Neurodegeneration, Liver disease, Kidney disease.
Please note that our chemical products are for research use only in a laboratory and are not for medical or veterinary use.
This product acts on the following target types: Kinase.
This product acts on the following biochemical pathways: Cell cycle, Apoptosis inducer, NFkappaB, Myc, Bcl.
This product may be interest in the following research areas and diseases: Neuroscience, Cell death, Ubiquitin/Proteasome, Cancer, Neurodegeneration, Liver disease, Kidney disease.
Please note that our chemical products are for research use only in a laboratory and are not for medical or veterinary use.
| Supplier | Abbexa Ltd. |
|---|---|
| Product # | abx283296-5MG |
| Pricing | 5 mg USD $217.5 |
| Availability | Shipped within 5-10 working days. |
| Dry Ice | No |
| Note |
|
| CAS Number | 294646-77-8 |